Coronary heart disease
Conditions
Interventions
control group:Conventional treatment
Sponsors
Affiliated Hospital of Chengdu University of traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
40 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Subjects meeting the diagnostic criteria of ACS; 2. Subjects aged 40 to 80 years; 3. Subjects with successful percutaneous coronary intervention (complete revascularization of target vessel); 4. Subjects with cardiac function I-III (NYHA classification); 5. Subjects who meet the syndrome differentiation standard of qi deficiency and blood stasis syndrome of chest stuffiness and heartache; 6. Subjects who signed informed consent and agreed to participate in the trial.
Exclusion criteria
Exclusion criteria: 1. Patients who need continuous mechanical adjuvant therapy after successful interventional therapy; 2. Patients with severe liver, kidney, hematopoiesis, nervous system diseases, psychosis and malignant tumor; 3. Pregnant or lactating women; 4. Allergic constitution and patients with suspected or definite allergy to related drugs; 5. Patients with persistent atrial fibrillation and fatal arrhythmia; 6. Patients whose compliance is poor and the possibility of follow-up is poor; 7. Patients who are participating in other clinical trials or in recent 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| NT-proBNP; | — |
Countries
China
Contacts
Public ContactFan Mingyuan
Affiliated Hospital of Chengdu University of traditional Chinese Medicine
Outcome results
None listed